Physician profile
Michael K Bowman
NPI 1376510073
$3,587.88
in general payments reported to CMS, 2019-2025
19 companies · $1,547 in 2025
The $1,547 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $105 · 2021: $118 · 2022: $429 · 2023: $330 · 2024: $810 · 2025: $1,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983 · Travel and Lodging: $606 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.17 |
| Travel and Lodging | $605.55 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,514.25 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $441.25 | 2021-2025 | Dupixent |
| Stryker Corporation | $329.02 | 2019-2023 | Scopis Ent |
| Glaxosmithkline, LLC. | $230.03 | 2021-2025 | Nucala |
| Optinose US, INC. | $179.61 | 2019-2025 | |
| Intuitive Surgical, INC. | $157.18 | 2022 | |
| Genzyme Corporation | $139.82 | 2022-2025 | |
| Aerin Medical INC. | $126.45 | 2024 | |
| Intersect Ent, INC. | $93.21 | 2019-2022 | |
| Galderma Laboratories, L.P. | $70.18 | 2022-2024 | |
| Organogenesis INC. | $57.78 | 2024-2025 | Affinity |
| Smith+Nephew, INC. | $53.32 | 2020-2025 | Oasis |
| Merck Sharp & Dohme LLC | $42.66 | 2023-2025 | Keytruda |
| Arbor Pharmaceuticals, INC. | $38.91 | 2019 | |
| Baxter Healthcare | $33.20 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.84 | 2019 | |
| Olympus America INC. | $19.65 | 2023 | Rhino-Laryngo Videoscope |
| Phadia US INC. | $15.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.